» Articles » PMID: 26477870

Association Between Clinical Outcomes and Hospital Guidelines for Cerebrospinal Fluid Testing in Febrile Infants Aged 29-56 Days

Overview
Journal J Pediatr
Specialty Pediatrics
Date 2015 Oct 20
PMID 26477870
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To describe the association between clinical outcomes and clinical practice guidelines (CPGs) recommending universal cerebrospinal fluid (CSF) testing in the emergency department for febrile infants aged 29-56 days.

Study Design: Using 2007-2013 administrative data from 32 US children's hospitals, we performed a difference-in-differences analysis comparing 7 hospitals with CPGs recommending universal CSF testing for older febrile infants aged 29-56 days (CPG group) with 25 hospitals without such CPGs (control group). We compared differences in clinical outcomes between older febrile infants with the corresponding differences among younger febrile infants aged 7-28 days. The primary outcome was the occurrence of an adverse event, defined as a delayed diagnosis of bacterial meningitis, mechanical ventilation, placement of a central venous catheter, extracorporeal membrane oxygenation, or in-hospital mortality. Analyses were adjusted for race/ethnicity, sex, median annual household income by zip code, primary insurance source, discharge season, and discharge year.

Results: The proportion of older febrile infants undergoing CSF testing was higher (P < .001) in the CPG group (64.8%) than the control group (47.8%). CPGs recommending universal CSF testing for older febrile infants were not associated with significant differences in adverse events (difference-in-differences: +0.31 percentage points, 95% CI -0.18 to 0.85; P = .22).

Conclusions: Hospital CPGs recommending universal CSF testing for febrile infants aged 29-56 days were not associated with significant differences in clinical outcomes.

Citing Articles

Boston Febrile Infant Algorithm 2.0: Improving Care of the Febrile Infant 1-2 Months of Age.

Dorney K, Neuman M, Harper M, Bachur R Pediatr Qual Saf. 2022; 7(6):e616.

PMID: 36337736 PMC: 9622664. DOI: 10.1097/pq9.0000000000000616.


Disparities and implicit bias in the management of low-risk febrile infants: a mixed methods study protocol.

Gutman C, Lion K, Aronson P, Fisher C, Bylund C, McFarlane A BMJ Open. 2022; 12(9):e063611.

PMID: 36127098 PMC: 9490627. DOI: 10.1136/bmjopen-2022-063611.


Use of Procalcitonin in a Febrile Infant Clinical Pathway and Impact on Infants Aged 29 to 60 Days.

Widmer K, Schmidt S, Bakel L, Cookson M, Leonard J, Tyler A Hosp Pediatr. 2021; 11(3):223-230.

PMID: 33597148 PMC: 8287898. DOI: 10.1542/hpeds.2020-000380.


Validation of Risk Stratification Criteria to Identify Febrile Neonates at Low Risk of Serious Bacterial Infection.

Rabiner J, Capua M, Golfeiz D, Shoag J, Avner J Glob Pediatr Health. 2019; 6:2333794X19845076.

PMID: 31069251 PMC: 6492348. DOI: 10.1177/2333794X19845076.


Analgesia for lumbar puncture in infants and children.

Goldman R Can Fam Physician. 2019; 65(3):192-194.

PMID: 30867175 PMC: 6515948.


References
1.
Aronson P, Thurm C, Williams D, Nigrovic L, Alpern E, Tieder J . Association of clinical practice guidelines with emergency department management of febrile infants ≤56 days of age. J Hosp Med. 2015; 10(6):358-65. PMC: 4456211. DOI: 10.1002/jhm.2329. View

2.
Baraff L, BASS J, Fleisher G, Klein J, McCracken Jr G, Powell K . Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research. Ann Emerg Med. 1993; 22(7):1198-210. DOI: 10.1016/s0196-0644(05)80991-6. View

3.
De S, Tong A, Isaacs D, Craig J . Parental perspectives on evaluation and management of fever in young infants: an interview study. Arch Dis Child. 2014; 99(8):717-23. DOI: 10.1136/archdischild-2013-305736. View

4.
Baraff L . Management of fever without source in infants and children. Ann Emerg Med. 2000; 36(6):602-14. DOI: 10.1067/mem.2000.110820. View

5.
Schwartz A, Landon B, Elshaug A, Chernew M, McWilliams J . Measuring low-value care in Medicare. JAMA Intern Med. 2014; 174(7):1067-76. PMC: 4241845. DOI: 10.1001/jamainternmed.2014.1541. View